Articolul precedent |
Articolul urmator |
417 1 |
Ultima descărcare din IBN: 2023-09-20 18:40 |
SM ISO690:2012 STRUȚĂ, Alina, ROTARU, Larisa, GROPPA, Liliana, AGACHI, Svetlana, PASCAL, Rodica, RĂZLOG, Tatiana. Particularităţile evolutive şi de tratament în glomerulonefritele cronice. In: Congresul consacrat aniversării a 75-a de la fondarea Universității de Stat de Medicină şi Farmacie „Nicolae Testemiţanu”, 21-23 octombrie 2020, Chişinău. Chişinău: USMF, 2020, p. 266. |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Congresul consacrat aniversării a 75-a de la fondarea Universității de Stat de Medicină şi Farmacie „Nicolae Testemiţanu” 2020 | ||||||
Congresul "Congresul consacrat aniversării a 75-a de la fondarea Universității de Stat de Medicină şi Farmacie „Nicolae Testemiţanu”" Chişinău, Moldova, 21-23 octombrie 2020 | ||||||
|
||||||
Pag. 266-266 | ||||||
|
||||||
Descarcă PDF | ||||||
Rezumat | ||||||
Background. Chronic glomerulonephritis develops gradually, can be detected occasionally in the absence of symptoms. The chronic type of the disease has no definite cause. Chronic glomerulonephritis is the cause of 35% to 55% of end-stage renal disease, depending on the country or region. Objective of the study. To establish and evaluate the prognosis of chronic glomerulonephritis depending on the treatment applied to patients with chronic glomerulonephritis. Material and Methods. A retrospective study was conducted, analyzing 60 cases with chronic glomerulonephritis, hospitalized in the nephrology department in IMSP SCR "Timofei Moșneaga" during 2018-2019, of which 50% women and 50% men. The age of the patients varies from 18 to 68 years, the average being of 47.04 ± 12.4. Patients were distributed according to age groups according to WHO all investigated completely Results. It was established - depending on the main clinical syndrome present: 29 (48.3%) patients - were mixed, 16 (26.6%) patients - with nephritic syndrome, 11 (18.3%) patients - with nephrotic syndrome, 3 (5%) patients - with hematuric form and 1 (1.6%) patient - with hypertensive syndrome. After treatment: 57 (95%) of all patients receive antihypertensive therapy; 52 (86.6%) patients receive diuretics; 49 (81.6%) patients receive statins; 31 (51.6%) patients administered glucocorticosteroids; 29 (48.3%) patients receive cytostatics; 20 (33.3%) are on antianemic therapy. Conclusion. The prognosis of chronic glomerulonephritis depends on the clinical form, the patient's compliance and the treatment administered, the mixed form is unfavorable. The treatment is complex, d |
||||||
Cuvinte-cheie chronic glomerulonephritis, evolution, treatment, glomerulonefritele cronice, evoluţie, Tratament |
||||||
|